A Study to Evaluate the Effects of Annovera and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol
Recruiting
18 years - 99 years
Female
Phase
N/A
60 participants needed
1 Location
Brief description of study
This
study involves research about Annovera, an FDA-approved contraceptive vaginal
system. The Annovera vaginal system is a ring made of a silicone rubber, which is
inserted into your vagina. Annovera contains 2 hormones. One is a progestin
called segesterone acetate (SA) and the other is an estrogen called ethinyl
estradiol (EE). Annovera releases small amounts of these hormones into your
body. The hormones keep you from releasing an egg so you do not get pregnant.
Birth control pills work the same way.
The purpose of this study is to find out
if using tampons and Annovera at the same time affects the amount of hormone
released into your blood from Annovera.
You will be
assigned randomly (by chance) to one of two study groups: Group 1 will use
Annovera alone during the first study month of the study and use tampons with
Annovera during the second study month; Group 2 will use tampons with Annovera
during the first study month and will use Annovera alone during the second
study month.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Women's health,OBGYN,menstrual
-
Age: 18 years - 99 years
-
Gender: Female
Updated on
04 Aug 2024.
Study ID: 834743
Find a site
,
Your Information has been sent successfully.
Send a message
Enter your contact details to connect with study team
Primary Contact
